Fibromyalgia, Systemic Lupus Erythematosus (SLE), and Evaluation of SLE Activity

被引:70
|
作者
Wolfe, Frederick [1 ]
Petri, Michelle [2 ]
Alarcon, Graciela S. [3 ]
Goldman, John [4 ]
Chakravarty, Eliza F. [5 ]
Katz, Robert S. [6 ]
Karlson, Elizabeth W. [7 ]
机构
[1] Univ Kansas, Sch Med, Natl Data Bank Rheumat Dis, Wichita, KS 67214 USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Univ Alabama, Birmingham, AL USA
[4] Emory Univ, Atlanta, GA 30322 USA
[5] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[6] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[7] Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ACTIVITY MEASURE; SYSTEMIC LUPUS ERYTHEMATOSUS ACTIVITY QUESTIONNAIRE; FIBROMYALGIA; NECROSIS FACTOR THERAPY; RHEUMATOID-ARTHRITIS; TENDER POINTS; ACTIVITY QUESTIONNAIRE; REVISED CRITERIA; DISEASE-ACTIVITY; CLASSIFICATION; PREVALENCE; VALIDATION; PAIN;
D O I
10.3899/jrheum.080212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine if fibromyalgia (FM) or fibromyalgia-ness (the tendency to respond to illness and psychosocial stress with fatigue, widespread pain, general increase in symptoms, and similar factors) is increased in patients with compared to those without systemic lupus erythematosus (SLE); to determine whether FM or fibromyalgia-ness biases the SLE Activity Questionnaire (SLAQ); and to determine if the SLAQ is overly sensitive to FM symptoms. Methods. We developed a 16-item SLE Symptom Scale (SLESS) modeled on the SLAQ and used that scale to investigate the relation between SLE symptoms and fibromyalgia-ness in 23,321 patients with rheumatic disease. FM was diaanosed by survey FM criteria, and fibroinyalgia-ness 41 was measured using the Symptom Intensity (SI) Scale. As comparison groups, we combined patients with rheumatoid arthritis and noninflammatory rheumatic disorders into an "arthritis" group and also utilized a physician-diagnosed group of patients with FM. Results. FM was identified in 22.1% of SLE and 17.0% of those with arthritis. The SI scale was minimally increased in SLE. The correlation between SLAQ and SLESS was 0.738. SLESS/SLAQ scale items (Raynaud's phenomenon, rash, fever, easy bruising, hair loss) were significantly more associated with SLE than FM, while the reverse was true for headache, abdominal pain, paresthesias/stroke, fatigue, cognitive problems, and muscle pain or weakness. There was no evidence of disproportionate symptom-reporting associated with fibromyalgia-ness. Self-reported SLE was associated with an increased prevalence of FM that was unconfirmed by physicians, compared to SLE confirmed by physicians. Conclusion. The prevalence of FM in SLE is minimally increased compared with its prevalence in patients with arthritis. Fibromyalgia-ness does not bias the SLESS and should not bias SLE assessments, including the SLAQ. (First Release Nov 1 2008; J Rheumatol 200936:82-88: doi: 10.3899/jrheum.080212)
引用
收藏
页码:82 / 88
页数:7
相关论文
共 50 条
  • [1] Fibromyalgia (FM) and disease activity in systemic lupus erythematosus (SLE).
    Petri, M
    Minor, M
    Magder, L
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S332 - S332
  • [2] Hypertrichosis in Systemic Lupus Erythematosus (SLE)
    M. Santiago
    A. C. Travassos
    M. C. Rocha
    S. Souza
    [J]. Clinical Rheumatology, 2000, 19 : 245 - 246
  • [3] EPILEPSY IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Hopia, L.
    Andersson, M. L.
    Svenungsson, E.
    Piehl, F.
    Tomson, T.
    [J]. EPILEPSIA, 2014, 55 : 99 - 99
  • [4] Myositis in Systemic Lupus Erythematosus (SLE)
    Niaki, Omid
    Pineau, Christian
    Vinet, Evelyne
    Grenier, Louis-Pierre
    Kalache, Fares
    Nashi, Emil
    Bernatsky, Sasha
    [J]. JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 795 - 795
  • [5] Treatment in systemic lupus erythematosus (SLE).
    Schroder, JO
    [J]. AKTUELLE RHEUMATOLOGIE, 1996, 21 (02) : 89 - 97
  • [6] Systemic lupus erythematosus and the SLE galaxy
    Meroni, P. L.
    Shoenfeld, Y.
    [J]. AUTOIMMUNITY REVIEWS, 2010, 10 (01) : 1 - 2
  • [7] Management of systemic lupus erythematosus (SLE)
    Morton, SJ
    Powell, RJ
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (05): : 686 - 693
  • [8] Menopause and systemic lupus erythematosus (SLE)
    Huong, DLT
    Boddaert, J
    Andreu, MR
    Wechsler, B
    Amoura, Z
    Godeau, P
    Piette, JC
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S583 - S583
  • [9] Hydroxychloroquine in systemic lupus erythematosus (SLE)
    Ponticelli, C.
    Moroni, G.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (03) : 411 - 419
  • [10] Etiopathogenesis of systemic lupus erythematosus (SLE)
    Herrmann, M
    Voll, RE
    Kolowos, W
    Lorenz, HM
    Kalden, JR
    [J]. IMMUNOLOGIST, 2000, 8 (03): : 66 - 71